J.P. Morgan: Enabling AI Implementation in Healthcare
J.P. Morgan stands as one of the biggest financial services firms in the world, holding assets totalling US$3.9tn.
Its teams of commercial and investment bankers, along with sector specialists, offer advice and support across major industries including retail, energy and healthcare.
When it comes to the healthcare sector, J.P. Morgan brings expertise in digital transformation, data security and AI adoption, helping providers adapt to an increasingly technology-led landscape.
Putting AI to work in clinical settings
J.P. Morgan brings healthcare leaders together to explore how AI can support better patient outcomes. In December 2025, the firm hosted its Healthcare Advisory Council, bringing together executives across the US to discuss practical AI adoption in healthcare environments.
One example shared at the event came from Hartford HealthCare – a provider with hospitals and facilities across the US – which works with the Massachusetts Institute of Technology (MIT) to co-develop AI platforms. Together they have launched tools including an emergency department scheduling system and a data analytics platform to track patient information in real time.
Their AI platform is shown to reduce the average length of stay for patients by one full day across six hospitals in Connecticut.
Elsewhere, Hartford HealthCare has adopted an AI system for clinical documentation across its network of physician practices. By easing the burden of documentation, the technology allows clinicians to maintain detailed records while spending more time on direct patient care.
Jeff Flaks, CEO at Hartford HealthCare, says: “This is the best time we’ve ever had in healthcare. You can get better, faster, now. The types of improvements we’re able to do with AI and machine-based learning and the ability to intervene quickly to make significant improvements is different today than ever before.”
Building resilience
J.P. Morgan also works with healthcare organisations to strengthen financial performance and operational resilience. As healthcare shifts to digital-first models, the firm offers tools to protect patient data and guard against fraud. Payment and digital solutions help employers manage costs, simplify billing and insurance communications, and cut out paper processes entirely.
This includes InstaMed, J.P. Morgan’s healthcare payments business. It delivers end-to-end payments, banking and treasury services tailored for healthcare. Using the firm’s own cloud-based technology, InstaMed supports electronic transactions, secure data handling and seamless payment processing.
InstaMed’s systems are designed to remove inefficiencies in payment workflows, allowing providers to reinvest saved time and costs into areas like patient care, research and new technology.
Jeff Lin, CEO of InstaMed, says: “In an era where healthcare organisations are deeply linked with a broad network of partners, robust cybersecurity is no longer optional – it’s essential. Extending protections to vendors, clients and suppliers is critical to maintaining trust and operational integrity.”
Sector support for life sciences and biotech
What's more, J.P. Morgan plays a key role in supporting life sciences companies, including those in biotechnology, pharmaceuticals, diagnostics and medical devices. It assists companies from start-up phase through to clinical development and commercialisation.
The bank provides support to help organisations manage financial and regulatory complexity, which can be a challenge across different stages of growth. Teams connect clients to international experts and assist with managing global operations, whether that involves product roll-out or regulatory navigation.
For biotech and pharmaceutical companies in particular, the bank tailors its services to specific subsectors of the industry. Its digital platforms are built to improve operational efficiency, cut costs and help businesses make quicker, better-informed decisions.
These platforms enable healthcare businesses to evolve at scale, with tools that focus on improving core systems while adapting to shifting industry demands. This includes support for digital payments, AI-backed analytics and strategic finance.
Whether it's enabling AI implementation, investing in payment modernisation or helping manage global biotech operations, J.P. Morgan is focused on enabling long-term growth and improved patient outcomes through secure, data-driven strategies.
